Grand Medical Group

About us

Grand Medical Group AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

read more

10 Kornmarkt Street, CH - 6004 Luzern, Switzerland

info@grandmedicalgroup.ch

+41 415880810

LEVADIDOZ

100 ml of solution for infusion contains 500 mg levofloxacin, vial No1

PHARMACOLOGIC PROPERTIES

ATC code: J01MA12, Quinolone antibacterials, ?uoroquinolones Levo?oxacin is a synthetic antibacterial agent of the ?uoroquinolone class and is the S (-) enantiomer of the racemic drug substance o?oxacin. As a ?uoroquinolone antibacterial agent, levo?oxacin acts on the DNA-DNA-gyrase complex and topoisomerase IV.

THERAPEUTIC INDICATIONS

Levo?oxacin solution for infusion is indicated in adults for the treatment of the following infections:

• Community-acquired pneumonia • Complicated skin and soft tissue infections
• For the above-mentioned infections levo?oxacin should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections
• Pyelonephritis and complicated urinary tract infections
• Chronic bacterial prostatitis
• Inhalation anthrax: postexposure prophylaxis and curative treatment


LEAFLETS